Company intelligence / Profile preview

AdvanBio

Irvine, California, United Statesadvan-bio.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

AdvanBio specializes in R&D and commercialization of clinical diagnostic products, including molecular technology, immunoassays, microbiology, and biochemistry. The company provides IVD quality control products and reagents to support precision medicine. No active clinical drug trials are listed; the focus is on enabling accurate diagnosis through advanced laboratory technologies.

Modalities: Diagnostic assayImmunoassayMolecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on AdvanBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AdvanBio.

Explore the full profile